Education
About Us
Working with TipRanks
Follow Us
Life Science Reit Plc (GB:LABS)
:LABS
RESEARCH TOOLSreports
Total Valuation
Life Science Reit Plc has a market cap or net worth of £151.55M. The enterprise value is 249.67M.
Market Cap£151.55M
Enterprise Value249.67M
Share Statistics
Life Science Reit Plc has 350,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding350,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Life Science Reit Plc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Life Science Reit Plc is ―. Life Science Reit Plc’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Life Science Reit Plc had revenue of 19.94M and earned -21.71M in profits. Earnings per share was -0.06.
Revenue19.94M
Gross Profit10.44M
Operating Income28.08M
Pretax Income-21.85M
Net Income-21.71M
EBITDA8.72M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was 13.37M and capital expenditures -37.54M, giving a free cash flow of -24.17M billion.
Operating Cash Flow13.37M
Free Cash Flow-24.17M
Free Cash Flow per Share-0.07
Dividends & Yields
Life Science Reit Plc pays an annual dividend of 0.999p, resulting in a dividend yield of 2.31%
Dividend Per Share0.999p
Dividend Yield2.31%
Payout Ratio99.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change12.70%
50-Day Moving Average41.07
200-Day Moving Average37.37
Relative Strength Index (RSI)51.17
Average Volume (3m)837.09K
Important Dates
Life Science Reit Plc upcoming earnings date is Sep 18, 2025, TBA Not Confirmed.
Last Earnings DateApr 16, 2025
Next Earnings DateSep 18, 2025
Ex-Dividend DateOct 03, 2024
Financial Position
Life Science Reit Plc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Life Science Reit Plc has paid -146.00K in taxes.
Income Tax-146.00K
Effective Tax Rate―
Enterprise Valuation
Life Science Reit Plc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Life Science Reit Plc has £10.51M in cash and marketable securities with £107.92M in debt, giving a net cash position of £107.56M billion.
Cash & Marketable Securities£10.51M
Total Debt£107.92M
Net Cash£107.56M
Net Cash Per Share£0.31
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Life Science Reit Plc is £37.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£37.00
Price Target Upside-15.33% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast1.84%
EPS Growth Forecast35.65%